Lisa M. Chelstrom
- Biotechnology top 5%
- Transgenic Plants and Applications 9
- Hematology top 10%
-
- Toxin Mechanisms and Immunotoxins 12
- Pathology and Forensic Medicine top 10%
-
- CAR-T cell therapy research 3
-
- Acute Lymphoblastic Leukemia research 12
-
- Thermoregulation and physiological responses 5
-
- Infrared Thermography in Medicine 5
-
- Synthesis and Biological Evaluation 4
-
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Fatih M. UckunL Tuel-AhlgrenChang W. SongDamian E. MyersEvans WeRoland GüntherJoseph B. BolenKG Waddick
- Cited by
- BiotechnologyHematologyImmunology
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Lisa M. Chelstrom
33 papers receiving 874 citations
Peers
Comparison fields: 5 of 95
- Biotechnology 99
- Hematology 125
- Immunology 213
- Pathology and Forensic Medicine 140
- Oncology 181
Countries citing papers authored by Lisa M. Chelstrom
This map shows the geographic impact of Lisa M. Chelstrom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa M. Chelstrom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa M. Chelstrom more than expected).
Fields of papers citing papers by Lisa M. Chelstrom
This network shows the impact of papers produced by Lisa M. Chelstrom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa M. Chelstrom. The network helps show where Lisa M. Chelstrom may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lisa M. Chelstrom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 13 | |
| 2 | 1998 | 1 | |
| 3 | 1998 | 4 | |
| 4 | 1998 | 20 | |
| 5 | 1998 | 3 | |
| 6 | 1998 | 64 | |
| 7 | In vivo biotherapy of HL-60 myeloid leukemia with a genetically engineered recombinant fusion toxin directed against the human granulocyte macrophage colony-stimulating factor receptor. | 1997 | 14 |
| 8 | 1996 | 17 | |
| 9 | 1996 | 6 | |
| 10 | 1995 | 5 | |
| 11 | 1995 | 78 | |
| 12 | Effective immunochemotherapy of human t(4;11) leukemia in mice with severe combined immunodeficiency (SCID) using B43 (anti-CD19)-pokeweed antiviral protein immunotoxin plus cyclophosphamide. | 1993 | 30 |
| 13 | 1993 | 14 | |
| 14 | 1992 | 7 | |
| 15 | 1990 | 28 | |
| 16 | Effects of a second heating on blood flow in tumors. | 1990 | 9 |
| 17 | 1990 | 7 | |
| 18 | 1989 | 51 | |
| 19 | 1989 | 23 | |
| 20 | 1987 | 42 |
About Lisa M. Chelstrom
Lisa M. Chelstrom is a scholar working on Biotechnology, Immunology and Hematology, having authored 33 papers that have together received 907 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (12 papers), Toxin Mechanisms and Immunotoxins (12 papers), Transgenic Plants and Applications (9 papers), Thermoregulation and physiological responses (5 papers), Infrared Thermography in Medicine (5 papers), Synthesis and Biological Evaluation (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Biotechnology (99 citations), Hematology (125 citations) and Immunology (213 citations). Lisa M. Chelstrom has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Fatih M. Uckun, L Tuel-Ahlgren, Chang W. Song, Damian E. Myers, Evans We, Roland Günther, Joseph B. Bolen, KG Waddick, Anne L. Burkhardt and Dorothea E. Myers. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.